Ho Lini | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

🌟Prof Dr. Ho Lini, Pharmacology, Best Researcher Award🏆

Professor at National Chung Hsing University, Taiwan

Ho Lin (Jack, 林 赫) is an accomplished scientist and educator with expertise in cell biology, neurobiology, pharmacology, reproduction, endocrinology, and cancer biology. Currently serving as the Executive Director of the Science & Technology Division at the Taipei Economic & Cultural Office in Australia and a Distinguished Professor at the Department of Life Sciences, National Chung Hsing University (NCHU), Taiwan, Ho Lin has made significant contributions to the field of biomedical research through his academic pursuits, administrative roles, and collaborative projects. With a background in physiology from National Yang Ming University and biology from Tunghai University, Ho Lin has a strong foundation in both theoretical knowledge and practical research methodologies.

Author Metrics:

Ho Lin has a prolific publication record, with numerous articles published in prestigious scientific journals. As an established researcher, he has contributed to advancing scientific knowledge in various areas of biology and medicine. His publications have been cited extensively, reflecting the impact of his work within the scientific community. Additionally, Ho Lin’s expertise is recognized through his editorial roles in esteemed journals and his participation in scholarly activities such as peer review and guest editing.

Scopus Profile

ORCID Profile

Citations: 2,207 across 1,858 documents

h-index: 27

Number of Documents Authored: 85

Education:

Ho Lin earned his Doctor of Philosophy (Ph.D.) in Physiology from National Yang Ming University and his Bachelor of Science (B.S.) in Biology from Tunghai University. His academic journey provided him with a solid foundation in biomedical sciences, shaping his subsequent career in research and academia. Through rigorous training and interdisciplinary studies, Ho Lin developed expertise in multiple fields, enabling him to conduct innovative research and mentor aspiring scientists.

Research Focus:

Ho Lin’s research interests encompass hormone receptors in cancer biology, novel functions of hormone receptors, and neurobiology. His investigations aim to unravel the molecular mechanisms underlying disease pathogenesis and identify potential therapeutic targets. By elucidating the roles of hormone receptors in cancer progression and exploring their diverse functions in physiological processes, Ho Lin contributes to the development of novel treatment strategies and diagnostic tools.

Professional Journey:

Ho Lin’s professional journey spans various academic and administrative roles, reflecting his commitment to advancing scientific knowledge and fostering academic excellence. From his early career as a postdoctoral fellow at the National Health Research Institutes to his current positions as an Executive Director and Distinguished Professor, Ho Lin has demonstrated leadership, expertise, and dedication to his field. His contributions to education, research, and institutional governance have earned him recognition and respect within the scientific community.

Honors & Awards:

Throughout his career, Ho Lin has received numerous honors and awards in recognition of his outstanding contributions to science and academia. These accolades include the NCHU Distinguished Professorship, Distinguished Mentorship, and grants for distinguished young scholars. Ho Lin’s achievements reflect his excellence in research, teaching, and mentorship, inspiring future generations of scientists and contributing to the advancement of biomedical sciences.

Publications Noted & Contributions:

Ho Lin’s publications are noted for their significance in advancing scientific knowledge and addressing critical questions in biology and medicine. His research contributions span a wide range of topics, including hormone receptor signaling, cancer biology, neurobiology, and pharmacology. Through his publications, Ho Lin has disseminated novel findings, proposed innovative hypotheses, and contributed to the scientific discourse on various biological processes and disease mechanisms.

Metformin alters dendrite development and synaptic plasticity in rat cortical neurons

Published in Biochemical and Biophysical Research Communications, May 2024.

DOI: 10.1016/j.bbrc.2024.149874

Contributors: Muhammet Oner, Pang-Ting Cheng, Hsin-Yi Wang, Mei-Chih Chen, Ho Lin

Dinaciclib inhibits the growth of acute myeloid leukemia cells through either cell cycle-related or ERK1/STAT3/MYC pathways

Published in Toxicology in Vitro, December 2023.

DOI: 10.1016/j.tiv.2023.105768

Contributors: Chieh-Lin Jerry Teng, Pang-Ting Cheng, Yu-Chiao Cheng, Jia-Rung Tsai, Mei-Chih Chen, Ho Lin

RAGE potentiates EGFR signaling and interferes with the anticancer effect of gefitinib on NSCLC cells

Published in American Journal of Physiology-Cell Physiology, November 1, 2023.

DOI: 10.1152/ajpcell.00494.2022

Contributors: Wan-Ling Liao, Ho Lin, Yu-Hsuan Li, Tsung-Ying Yang, Mei-Chih Chen

Impacts of androgen pathway manipulation on patients with lung cancer

Published in Journal of Clinical Oncology, June 1, 2023.

DOI: 10.1200/jco.2023.41.16_suppl.e21010

Contributors: Po-Hsin Lee, Jeng-Sen Tseng, Yen-Hsiang Huang, Yu-Wei Hsu, Kuo-Hsuan Hsu, Tsung-Ying Yang, Ho Lin

Abstract A12: Androgen receptor inhibition is involved in Finasteride-reduced AML cell proliferation

Published in Blood Cancer Discovery, May 1, 2023.

DOI: 10.1158/2643-3249.aml23-a12

Contributors: Pang-Ting Cheng, Chieh-Lin Jerry Teng, Yu-Chiao Cheng, Mei-Chih Chen, Ho Lin

Research Timeline:

Ho Lin’s research timeline reflects a progressive trajectory characterized by continuous growth, innovation, and collaboration. From his early explorations as a graduate student to his current leadership roles, Ho Lin’s research journey has been marked by significant achievements, breakthroughs, and interdisciplinary collaborations. Through a combination of basic and translational research, Ho Lin has made notable contributions to understanding disease pathogenesis and developing therapeutic interventions.

Collaborations and Projects:

Ho Lin has actively engaged in collaborative projects with researchers and institutions worldwide, leveraging collective expertise and resources to address complex scientific challenges. His collaborations encompass multidisciplinary teams and interdisciplinary approaches, fostering innovation and knowledge exchange. By collaborating with diverse stakeholders, Ho Lin promotes synergistic research efforts and accelerates the translation of scientific discoveries into clinical applications.

Ke Yang | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

🌟Assoc Prof Dr. Ke Yang, Pharmacology, Best Researcher Award🏆

  •  Associate Professor at China Jiliang University, China

Yang Ke is a prominent figure in the field of Pharmacology of Traditional Chinese Medicine. With a background in Pharmacognosy and Molecular Biology and Biochemistry, Yang has made significant contributions to research and academia. Currently serving as an Associate Professor at China Jiliang University and as a Postdoctoral Researcher at the China Academy of Chinese Medical Sciences, Yang’s expertise lies in the study of medicinal plants and their therapeutic applications. With a focus on elucidating the molecular mechanisms underlying the pharmacological effects of natural compounds, Yang’s research has garnered recognition both nationally and internationally.

Author Metrics

Scopus Profile

Yang Ke’s scholarly impact is reflected in their author metrics, including citation counts, h-index, and publication metrics. Their publications have garnered attention from researchers worldwide, highlighting the significance of their contributions to the field.

Affiliation: China Jiliang University, Hangzhou, China

Scopus Author Identifier: Yang Ke’s publications are indexed in Scopus, a database of peer-reviewed literature, enabling tracking of citations and other metrics related to their scholarly work.

Citations: Yang Ke has received a total of 42 citations across 42 documents, indicating the impact of their research within the academic community.

Documents: Yang Ke has authored or co-authored 5 documents, which have contributed to their citation count.

h-index: The h-index is a metric used to measure both the productivity and impact of a researcher’s publications. With an h-index of 2, Yang Ke has published at least 2 papers that have each received at least 2 citations.

Education

Yang Ke pursued a Ph.D. in Pharmacognosy at Peking Union Medical College, where they investigated the therapeutic potential of natural products. Prior to this, Yang completed a Master’s degree in Molecular Biology and Biochemistry at China Jiliang University, laying the foundation for their interdisciplinary approach to research.

Research Focus

Yang Ke’s research primarily focuses on the pharmacology of traditional Chinese medicine, particularly the therapeutic properties of medicinal plants. Their work involves identifying bioactive compounds, elucidating their mechanisms of action, and exploring their potential applications in treating various diseases. Key areas of interest include diabetic peripheral neuropathy, atherosclerosis, and neurodegenerative disorders.

Professional Journey

Yang Ke’s professional journey encompasses roles as a Postdoctoral Researcher at the China Academy of Chinese Medical Sciences and an Associate Professor at China Jiliang University. Additionally, they have undertaken a secondment at the National Institute of Extremely-Weak Magnetic Field Infrastructure in Hangzhou. Through these positions, Yang has been instrumental in advancing research, mentoring students, and collaborating with esteemed colleagues in the field.

Honors & Awards

Throughout their career, Yang Ke has received recognition for their outstanding contributions to pharmacological research. Notable honors and awards include grants from national research and development plans, prestigious fellowships, and accolades for impactful publications.

Publications Noted & Contributions

Yang Ke has made significant contributions to the scientific community through their research publications. Notable works include studies on the therapeutic effects of natural compounds in diabetic neuropathy, atherosclerosis, and Alzheimer’s disease. Their research has been published in esteemed journals and has contributed to advancing knowledge in the field of pharmacology.

Structure of crude polysaccharides from Atractylodes lancea rhizome and treatment of diarrhea owing to spleen deficiency through intestinal flora

Authors: Wang, Y., Wang, S., Wang, T.-L., … Yang, K., Guo, L.-P.

Journal: Biomedical Chromatography, 2024

Citation Count: 0

A smartphone-integrated multi-model thermal immunochromatographic assay for sensitive detection of histamine in real samples

Authors: Zhang, B., Cai, D., Lang, Y., … Shentu, X., Yu, X.

Journal: Sensors and Actuators B: Chemical, 2023

Citation Count: 2

Research progress on effects of traditional Chinese medicine on myocardial ischemia–reperfusion injury: A review

Authors: Xing, N., Long, X.-T., Zhang, H.-J., … Yang, K., Lin, H.-B.

Journal: Frontiers in Pharmacology, 2022

Citation Count: 2

Overview of the preparation method, structure and function, and application of natural peptides and polypeptides

Authors: Feng, L., Wang, Y., Yang, J., … Lin, H.-B., Yang, K.

Journal: Biomedicine and Pharmacotherapy, 2022

Citation Count: 9

Progress in the treatment of diabetic peripheral neuropathy

Authors: Yang, K., Wang, Y., Li, Y.-W., … Zhou, P., Yu, X.-P.

Journal: Biomedicine and Pharmacotherapy, 2022

Citation Count: 32

Research Timeline

Yang Ke’s research timeline spans several years, encompassing their doctoral and postdoctoral studies, as well as their tenure as an Associate Professor. Over this period, they have undertaken various research projects, secured funding, and published numerous papers, contributing to the advancement of pharmacological research.

Collaborations and Projects

Yang Ke has engaged in collaborative research projects with colleagues both within their institution and internationally. These collaborations have led to interdisciplinary research endeavors, innovative discoveries, and the development of novel therapeutic approaches. Through active involvement in projects, Yang has fostered collaborations and contributed to the advancement of scientific knowledge in their field.